NICE could provide early advice to pharma companies on the data it requires for its appraisals, if a new pilot …
It hardly needs to be said that each wave of NHS reorganisation has brought new challenges in terms of pharma …
Japanese pharma company Eisai has acquired Minnesota-based biotech MGI Pharma for $3.9 billion, significantly boosting its oncology business.It is Eisai’s …
The government's pledge to build 100 new practices in under-doctored areas could make health inequalities in Britain even worse, according …
Bayer Schering says its new blood clotting drug Xarelto is poised to set a new standard of care for post-surgery …
GSK has secured two new early-stage biotech licensing deals to boost its product pipeline.The UK-based group unveiled one partnership with …
NICE is set to change its guidance for blindness treatment Lucentis following a barrage of complaints over its failure to …
No one looks forward to receiving a letter from the MHRA (Medicines and Healthcare products Regulatory Agency) inspectorate announcing their …
A revolutionary new 'public service trust' has been created in Herefordshire, and will be the first to integrate a PCT …
The NHS could face steeper prices on drugs due to manufacturers adopting a new restrictive distribution model, according to a …
GlaxoSmithKline has unveiled new appointments to its board of directors and the departure of its current president of Pharmaceuticals David …
Pharmaceutical industry leaders are hoping that 2008 will see a breakthrough on one of the most contentious issues in European …
New research by market data company TNS Healthcare suggests that fewer patients are being taken off Avandia in Europe than …
The chairman of the NHS Alliance has criticised a new report which says GPs are not carrying out 'basic work' …
Eisai is to make one more legal challenge to NICE by taking its case on Alzheimer’s drugs to the Court …
AstraZeneca's Chris Brinsmead has been named as the next president of the ABPI.He will take over from the current ABPI …
Adventrx completes enrolment for breast cancer trialAdventrx Pharmaceuticals has completed patient enrolment in its Phase II clinical trial of CoFactor …
There is a tide of change in drug safety within the pharmaceutical industry. Internal and external forces are pushing drug …
NICE has recommended Novartis' injection Xolair for asthma patients whose condition cannot be controlled by conventional first-line treatments. Patients with …
Health secretary Alan Johnson has unveiled plans to open 100 new practices in under-doctored areas within the next three years. …